Risk factors for ptld - Study guides, Class notes & Summaries

Looking for the best study guides, study notes and summaries about Risk factors for ptld? On this page you'll find 34 study documents about Risk factors for ptld.

Page 4 out of 34 results

Sort by

BMTCN exam 2024 with 100% correct answers

BMTCN exam 2024 with 100% correct answers
Exam (elaborations) • 7 pages • 2023

What type of transplants commonly have PTLD as a secondary malignancy? - correct answer Allo HSCT with T-cell depleted graft Therapies associated with therapy-related acute leukemia and MDS - correct answer alkylating agents (eg. Cytoxan, cisplatin, melphalan, busulfan, ifos) , radiation, topoisomerase II inhibitors (eg. doxorubicin, etoposide, mitoxantrone) Genetic predispositions that increase risk of primary and secondary cancers - correct answer neurofibromatosis type 1, Fanconi ...

(0)
$16.49
+ learn more

Preview 2 out of 7 pages

Add to cart

Exam (elaborations)

(0)

Last document update: ago

$16.49

Add to cart

Show more info

BMTCN EXAM 2023 WITH 100% CORRECT ANSWERS

BMTCN EXAM 2023 WITH 100% CORRECT ANSWERS
Exam (elaborations) • 7 pages • 2023

What type of transplants commonly have PTLD as a secondary malignancy? Allo HSCT with T-cell depleted graft Therapies associated with therapy-related acute leukemia and MDS alkylating agents (eg. Cytoxan, cisplatin, melphalan, busulfan, ifos) , radiation, topoisomerase II inhibitors (eg. doxorubicin, etoposide, mitoxantrone) Genetic predispositions that increase risk of primary and secondary cancers neurofibromatosis type 1, Fanconi anemia Risk factors for PTLD T-cell de...

(0)
$16.49
+ learn more

Preview 2 out of 7 pages

Add to cart

Exam (elaborations)

(0)

Last document update: ago

$16.49

Add to cart

Show more info

BMTCN Complete Solutions With Satisfactory Tests Graded A+
Exam (elaborations) • 5 pages • 2023

BMTCN Complete Solutions With Satisfactory Tests Graded A+ What type of transplants commonly have PTLD as a secondary malignancy? Correct Answer: Allow HSCT with T-cell depleted graft Therapies associated with therapy-related acute leukemia and MDS Correct Answer: alkylating agents (eg. Cytoxan, cisplatin, melphalan, busulfan, ifos) , radiation, topoisomerase II inhibitors (eg. doxorubicin, etoposide, mitoxantrone) Genetic predispositions that increase risk of primary and secondary cancer...